TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -0 | -3 | -8 | -14 | -53 | -53 | -22 |
| S | %wins | 100 | 100 | 67 | 33 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/18/06 14:26 | 5/17/06 | NBIX | Neurocrine Biosciences Inc | CA | Health | BioPrd | Biological Products, (No Diag | Hawran Paul W | CA | O | EVP,CFO | S | -2,286 | 19.79 | 33 | -115 | -24 | 360 | B | -1 | -4 | -23 | -52 | -55 | -42 | ||||||||
12/21/05 19:31 | 12/21/05 | NBIX | Neurocrine Biosciences Inc | CA | Health | BioPrd | Biological Products, (No Diag | Hawran Paul W | CA | O | EVP,CFO | S.d | -647 | 64.69 | 31 | -10 | -2 | 505 | M | 16 | 28 | 43 | 32 | 12 | 4 | 1 | 1 | 0 | 0 | -6 | 8 | -81 | -87 |
2/12/04 16:05 | 2/11/04 | NBIX | Neurocrine Biosciences Inc | CA | Health | BioPrd | Biological Products, (No Diag | Hawran Paul W | CA | O | EVP,CFO | S | -567 | 56.68 | 26 | -10 | -9 | 105 | D | 52 | 38 | 14 | 18 | 3 | 0 | 1 | 3 | 0 | -6 | 4 | 2 | -22 | -30 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |